Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 79.91 | N/A |
| PEG Ratio (TTM) | -44.64 | N/A |
| P/S Ratio (TTM) | 19.21 | N/A |
| P/B Ratio (TTM) | 18.20 | N/A |
| P/FCF Ratio (TTM) | 87.87 | N/A |
| Price to 5YR AVG Earnings Ratio | 99.57 | N/A |
| Price to 5YR AVG FCF Ratio | 86.01 | N/A |
Profitability (90%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.34% | N/A |
| ROE (TTM) | 26.32% | N/A |
| Net Profit Margin (TTM) | 23.87% | N/A |
| ROIC 5YR AVG | 36.99% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.23% | 54.85% | 42.22% |
| Revenue | 4.65% | 11.83% | 13.90% |
| Net Income | 0.06% | 54.52% | 41.64% |
| Cash Flow | 21.57% | 22.11% | 17.56% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.45 | N/A |
| Quick Ratio (TTM) | 2.27 | N/A |
| D/E Ratio (TTM) | 0.62 | N/A |
| Interest Coverage (TTM) | 22.43 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 13.05 | N/A |
| LTL to 5YR AVG FCF | 0.43 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.32% | N/A |